Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Sunday, 24 January 2016
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Stephen Opat
et al
. published in the
New England Journal of Medicine
.
Read article
here
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment